Phenotypic genotypic discordance environmental bacteria

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-27

Quick Answer

• Whole-genome sequencing detects resistance genes that may be silent, truncated, or poorly expressed, so genotypic predictions can disagree with phenotypic minimum inhibitory concentration (MIC) results in environmental isolates.
• Investigate discordance systematically by verifying culture purity, repeating susceptibility testing, checking gene expression and mutations, and comparing results against curated resistance databases.
• Discordance does not automatically mean an error, it can reflect real biological variation, database gaps, or technical artifacts that require careful interpretation before reporting.

At a Glance

Understanding Phenotypic and Genotypic Discordance

Antimicrobial resistance testing in environmental bacteria presents a distinct interpretive challenge. Phenotypic testing measures the observable response of a bacterial isolate to an antimicrobial agent under standardized conditions, typically expressed as a minimum inhibitory concentration (MIC). Genotypic testing, most commonly through whole-genome sequencing (WGS), detects the presence of resistance genes in the bacterial DNA. The two approaches answer different questions. Phenotypic testing asks what the organism does in the laboratory, while genotypic testing asks what genetic potential the organism carries.

Discordance occurs when these two answers do not align. A researcher may sequence an environmental isolate, identify a resistance gene such as a beta-lactamase or an aminoglycoside-modifying enzyme, and then find that the isolate is phenotypically susceptible to the corresponding drug. Alternatively, an isolate may show phenotypic resistance with no identifiable resistance gene in its genome. Both situations are common in environmental microbiology and require systematic investigation instead of immediate dismissal of one result.

The stakes of this discordance matter for several reasons. Environmental bacteria serve as reservoirs of resistance genes that can transfer to clinically relevant pathogens. Surveillance programs rely on accurate resistance data to track the spread of these genes. Misinterpreting discordance can lead to false alarms about emerging resistance threats or missed warnings about actual resistance mechanisms. The World Health Organization identifies antimicrobial resistance as a global public health concern, and accurate detection and reporting are foundational to surveillance and stewardship efforts.

Why Environmental Isolates Present Unique Challenges

Environmental bacteria differ from clinical isolates in ways that make discordance more likely. Clinical isolates are typically recovered from infected patients and have been subject to selective pressure from antimicrobial use. Environmental isolates come from soil, water, sediment, and other natural habitats where antimicrobial exposure may be intermittent or absent. The resistance genes they carry may serve natural ecological functions, such as self-protection in antibiotic-producing organisms or signaling molecules, instead of defense against therapeutic drugs.

The genetic context of environmental resistance genes also differs. A gene that confers resistance in a clinical isolate may be present in an environmental isolate as a remnant, a partial sequence, or a variant with altered function. Regulatory elements that control gene expression may differ between species. A gene that is inducible in one organism may be constitutively expressed in another, or vice versa. These biological variables create genuine discordance that reflects the complexity of bacterial ecology.

Technical factors compound the problem. Environmental samples often contain mixed populations, and the isolate selected for testing may not be pure. DNA extraction and sequencing can introduce errors. The databases used to identify resistance genes are built primarily from clinical isolates and may not contain the full diversity of environmental resistance determinants. Each of these factors can produce discordance that has nothing to do with the biology of the isolate.

Core Principles of Resistance Testing

Phenotypic Susceptibility Testing

Phenotypic susceptibility testing measures the growth of a bacterium in the presence of an antimicrobial agent. The most common methods include broth dilution, agar dilution, and disk diffusion. Broth dilution produces a quantitative MIC value, which is the lowest concentration of the antimicrobial that inhibits visible growth. Disk diffusion produces a qualitative result based on the diameter of the zone of inhibition around a disk containing the antimicrobial.

Standardized methods are essential for reproducible results. The Clinical and Laboratory Standards Institute (CLSI) publishes standards for antimicrobial susceptibility testing that define the media, inoculum density, incubation conditions, and interpretation criteria for clinical isolates. These standards are designed primarily for organisms that cause human disease, and their applicability to environmental isolates is not always straightforward. Breakpoints, the concentrations that define susceptible and resistant categories, are established based on clinical outcomes and pharmacokinetic data, which may not apply to environmental organisms.

For environmental isolates, the laboratory must decide whether to use clinical breakpoints, epidemiological cut-off values, or no interpretive criteria at all. Many environmental studies report MIC distributions without assigning susceptible or resistant categories. This approach avoids the problem of applying clinical breakpoints to organisms for which they were not designed. The choice of interpretive framework should be documented in the study methods and considered when interpreting discordance.

Genotypic Resistance Detection

Whole-genome sequencing provides a complete picture of the genetic content of an isolate. Resistance gene detection typically involves comparing the assembled genome against curated databases of known resistance genes. The most commonly used databases include the Comprehensive Antibiotic Resistance Database (CARD), ResFinder, and the National Database of Antibiotic Resistant Organisms (NDARO). Each database has its own criteria for what constitutes a resistance gene and how sequence similarity is scored.

The output of a resistance gene search is a list of genes with associated scores or percentage identities. A common threshold is 90 percent identity over a certain percentage of the gene length, but the specific thresholds vary by database and by the user's settings. A gene that matches a database entry at 95% identity is likely to be a functional resistance gene, while a gene that matches at 70% identity may be a distant homolog with unknown function. The choice of threshold affects the sensitivity and specificity of the detection.

The presence of a resistance gene in the genome does not guarantee that the gene is expressed or that it confers resistance. The gene may be truncated, contain a frameshift mutation, or have a promoter that is not recognized by the host RNA polymerase. The gene product may be produced but not functional. The gene may be expressed but the protein may not reach the location where it needs to act. These possibilities mean that genotypic detection is a prediction of resistance potential, not a measurement of resistance activity.

The Systematic Discordance Investigation Workflow

Step 1: Verify the Isolate and Test Conditions

The first step in investigating discordance is to confirm that the isolate being tested is pure and correctly identified. Environmental samples frequently contain multiple organisms, and a colony picked for testing may contain a mixture. A mixed culture can produce misleading phenotypic results if one organism is resistant and another is susceptible. The same issue can affect sequencing if the DNA is extracted from a mixed culture.

Confirm the isolate purity by streaking for isolated colonies on a non-selective medium and examining the colony morphology. Confirm the species identification using a method independent of the initial identification, such as 16S rRNA gene sequencing or MALDI-TOF mass spectrometry. The American Type Culture Collection (ATCC) provides authenticated reference strains that can be used as controls for both identification and susceptibility testing. Using authenticated strains ensures that the test system is working correctly and provides a baseline for comparison.

Check the test conditions against the standard method. The inoculum density, the medium, the incubation temperature, and the incubation time all affect the MIC result. A deviation from the standard protocol can produce a false result. The Clinical and Laboratory Standards Institute (CLSI) publishes detailed protocols for susceptibility testing, and the laboratory should verify that the test was performed according to the appropriate standard.

Step 2: Repeat the Phenotypic Test

A single phenotypic result is not sufficient to confirm discordance. Repeat the susceptibility test using the same method and also using an independent method if possible. For example, if the initial test was a broth dilution, repeat it and also perform a disk diffusion test. The two methods should produce consistent results. If they do not, the problem is likely in the testing system instead of in the biology of the isolate.

Include appropriate quality control strains in each test run. The quality control strains are reference strains with known susceptibility patterns. If the quality control results are outside the expected range, the test results are invalid and must be repeated. The ATCC provides reference strains that are suitable for quality control in susceptibility testing.

Document the repeat results and compare them with the initial results. If the repeat results are consistent with the initial results, the discordance is likely to be real. If the repeat results differ, the initial result was likely an error, and the discordance is resolved.

Step 3: Examine the Resistance Gene Sequence

If the phenotypic result is confirmed and the discordance persists, examine the resistance gene sequence in detail. The gene may be present in the genome but not be a functional resistance gene. Look for mutations that would disrupt the coding sequence, such as premature stop codons, frameshift mutations, or deletions. A gene with a premature stop codon will produce a truncated protein that is unlikely to be functional.

Check the promoter region of the gene. The promoter is the DNA sequence that the RNA polymerase binds to initiate transcription. A mutation in the promoter can reduce or eliminate gene expression. The gene may be present in the genome but not transcribed, or transcribed at a level too low to confer resistance.

Compare the gene sequence to the database entry. The database entry may be a variant that is not identical to the gene in the isolate. The isolate gene may have mutations that alter the function of the protein. The protein may still be functional but with a different substrate profile or a different level of activity. The database may not contain the specific variant present in the isolate.

Step 4: Assess Gene Expression

If the gene sequence appears intact and the promoter appears functional, the next step is to assess whether the gene is expressed. Gene expression can be measured at the RNA level using reverse transcription PCR (RT-PCR) or RNA sequencing. The presence of messenger RNA indicates that the gene is being transcribed. The amount of messenger RNA provides a measure of the level of transcription.

Gene expression can also be measured at the protein level. Proteomic methods such as mass spectrometry can detect the presence of the resistance protein in the bacterial cell. The protein may be present but not functional, or the protein may be present in insufficient quantity to confer resistance.

The expression of a resistance gene may be inducible. The gene may be expressed only in the presence of the antimicrobial agent. The phenotypic test may have been performed under conditions that did not induce the gene. Testing the isolate in the presence of a sub-inhibitory concentration of the antimicrobial may induce the gene and produce a different phenotypic result.

Step 5: Check the Database and the Analysis

The resistance gene database may not contain the gene present in the isolate. The database may be incomplete, or the gene may be a novel variant that has not been characterized. The database search may have missed the gene because the sequence identity was below the threshold, or the gene may have been detected but not annotated as a resistance gene.

Review the database search results carefully. The search may have detected a gene with a low score that was not reported in the final results. The search may have detected a gene that is not in the database but is similar to a known resistance gene. The search may have detected a gene that is a resistance gene but is not annotated as such in the database.

The databases are updated regularly, and the search should be repeated with the most current version of the database. The search should also be repeated with different databases to compare the results. A gene that is detected by one database but not by another may be a variant that is not well represented in the databases.

Step 6: Consider Alternative Resistance Mechanisms

The isolate may be resistant to the antimicrobial agent through a mechanism that is not detected by the resistance gene database. The resistance may be due to a mutation in a gene that is not a resistance gene. For example, mutations in the genes encoding the target of the antimicrobial agent can confer resistance. The target gene may be present in the genome but not annotated as a resistance gene.

The resistance may be due to an efflux pump that is not annotated as a resistance gene. Efflux pumps are transport proteins that pump antimicrobial agents out of the cell. Many efflux pumps have broad substrate specificity and can pump multiple classes of antimicrobial agents. The genes encoding efflux pumps may not be in the resistance gene database.

The resistance may be due to a change in the permeability of the cell membrane. A mutation that reduces the number of porins in the outer membrane can reduce the uptake of the antimicrobial agent. The porin genes may not be annotated as resistance genes.

Step 7: Consider the Phenotypic Test Limitations

The phenotypic test may not be appropriate for the isolate being tested. The test may have been designed for a different species, and the growth conditions may not be optimal for the isolate. The isolate may grow slowly, and the incubation time may not be sufficient for the isolate to reach the appropriate density.

The phenotypic test may not be able to detect the resistance mechanism. The test may be designed to detect a specific mechanism, and the isolate may have a different mechanism. The test may be designed to detect resistance in a specific species, and the isolate may be a different species.

The phenotypic test may have been performed with the wrong antimicrobial agent. The test may have been performed with a drug that is not the appropriate drug for the isolate. The test may have been performed with a drug that is not stable under the test conditions.

Step 8: Document and Report

The final step is to document the investigation and report the results. The documentation should include the initial results, the repeat results, the sequence analysis, the expression analysis, and the database search results. The documentation should include the interpretation of the discordance and the conclusion.

The report should state the phenotypic result and the genotypic result. The report should state the discordance and the likely cause. The report should state the limitations of the analysis and the confidence in the conclusion.

The report should be shared with the relevant stakeholders. The report may be shared with the laboratory director, the study team, or the funding agency. The report may be published in a scientific journal or presented at a conference.

Common Failure Patterns in Discordance Investigation

Failure to Confirm Isolate Purity

The most common failure in discordance investigation is the failure to confirm the purity of the isolate. A mixed culture can produce a phenotypic result that does not reflect the genotype of the isolate. The isolate may be a mixture of two organisms, one resistant and one susceptible. The phenotypic result may be susceptible, while the genotype of the resistant organism is detected in the sequencing.

The solution is to confirm the purity of the isolate before proceeding with the investigation. The isolate should be streaked for isolated colonies on a non-selective medium. The colony morphology should be examined. The species identification should be confirmed using an independent method.

Failure to Repeat the Phenotypic Test

A single phenotypic result is not sufficient to confirm discordance. The test may have been performed incorrectly, or the test may have been performed under conditions that were not optimal. The result may be a false result.

The solution is to repeat the phenotypic test using the same method and also using a different method. The repeat results should be consistent with the initial results. If the repeat results differ, the initial result was likely a problem.

Failure to Examine the Gene Sequence

The resistance gene may be present in the genome but not be functional. The gene may be truncated, mutated, or have a disrupted promoter. The gene may be present in the genome but not be expressed.

The solution is to examine the gene sequence in detail. The gene should be compared to the database entry. The gene should be examined for mutations that would disrupt the function. The promoter region should be examined for mutations that would disrupt transcription.

Failure to Consider Alternative Mechanisms

The isolate may be resistant through a mechanism that is not encoded by a resistance gene. The mechanism may be a mutation in the target gene, an efflux pump, or a change in membrane permeability. The database may not contain the gene that encodes the mechanism.

The solution is to consider alternative mechanisms. The isolate should be screened for mutations in the target gene. The isolate should be screened for efflux pumps. The isolate should be screened for changes in membrane permeability.

Failure to Use Appropriate Quality Controls

The phenotypic test may have been performed without appropriate quality controls. The quality controls are essential for ensuring that the test is working correctly. The quality control strains should be included in each test run.

The solution is to include appropriate quality controls in each test run. The quality control strains should have known MIC patterns. The quality control results should be within the expected range.

Records and Measurements for Discordance Investigation

Essential Records

The discordance investigation should be documented in a laboratory notebook or an electronic laboratory information management system. The records should include the following information:

• The isolate identification and source
• The species identification and the method used
• The phenotypic test results, including the MIC values and the interpretation
• The genotypic test results, including the resistance genes detected and the database used
• The sequence analysis results, including the gene sequence and the mutations
• The expression analysis results, including the RNA and protein data
• The alternative mechanism screening results
• The conclusion and the rationale

The records should be complete and accurate. The records should be dated and signed. The records should be stored in a secure location.

Measurements and Metrics

The discordance investigation should include measurements of the key parameters. The measurements should be recorded in the laboratory notebook.

The MIC values should be recorded for each antimicrobial agent tested. The MIC values should be recorded in micrograms per milliliter. The MIC values should be interpreted according to the appropriate breakpoints.

The resistance gene detection should be recorded with the gene name, the database, and the score. The score should be recorded as a percentage identity and a percentage coverage.

The gene expression should be recorded as the relative expression level. The expression level should be compared to a reference gene.

The alternative mechanism screening results should be recorded as the presence or absence of the mechanism.

Data Quality Controls

The data quality should be assessed throughout the investigation. The quality controls should be included in each test run. The quality control results should be within the expected range.

The sequence data should be assessed for quality. The sequence should be checked for the number of reads, the coverage, and the quality scores. The sequence should be checked for contamination.

The database search results should be assessed for quality. The search results should be checked for the number of genes detected. The search results should be checked for the score of each gene.

Biosafety and Laboratory Practice Considerations

Risk Assessment for Environmental Isolates

Environmental isolates may contain organisms that are not well characterized. The risk assessment should be performed before the isolate is brought into the laboratory. The risk assessment should consider the source of the isolate, the species, and the potential for the isolate to be a pathogen.

The Biosafety in Microbiological and Biomedical Laboratories (BMBL) provides guidance for the risk assessment and the containment of biological agents. The BMBL describes the biosafety levels and the practices for each level. The laboratory should follow the BMBL guidance for the handling of environmental isolates.

The laboratory should have a biosafety manual that describes the procedures for handling the isolates. The laboratory should have a biosafety officer who is responsible for the biosafety program. The laboratory should have a training program for the staff.

Containment and Decontamination

The laboratory should have the appropriate containment for the isolates. The containment should be based on the risk assessment. The containment may include a biosafety cabinet, a laboratory coat, and gloves.

The laboratory should have a decontamination procedure for the waste and the equipment. The decontamination should be performed using an appropriate method. The decontamination method should be validated.

The laboratory should have a procedure for the disposal of the waste. The waste should be disposed of in accordance with the regulations.

Professional Practice and Training

The laboratory should have a training program for the staff. The training should include the procedures for the handling of the isolates. The training should include the procedures for the susceptibility testing. The training should include the procedures for the sequencing.

The American Society for Microbiology (ASM) provides professional education and training for the microbiology workforce. The ASM provides resources for the laboratory practice and the quality. The laboratory should use the ASM resources for the training of the staff.

The laboratory should have a quality assurance program. The quality assurance program should include the proficiency testing. The proficiency testing should be performed on a regular basis.

Limitations of the Discordance Investigation

Database Limitations

The resistance gene databases are incomplete. The databases are built from the known resistance genes. The databases may not contain the resistance genes that are present in the environment. The databases may not contain the variants of the resistance genes that are present in the environment.

The database search results are dependent on the database and the search parameters. The search parameters include the identity threshold and the coverage threshold. The search parameters may be different for different databases.

The database search results are dependent on the quality of the sequence. The sequence may have errors. The sequence may be incomplete. The sequence may be contaminated.

Phenotypic Testing Limitations

The phenotypic testing methods are designed for clinical isolates. The methods may not be appropriate for environmental isolates. The growth conditions may not be optimal for the environmental isolate. The breakpoints may not be appropriate for the environmental isolate.

The phenotypic testing methods may not be able to detect the resistance mechanism. The method may be designed to detect a specific mechanism. The environmental isolate may have a different mechanism.

The phenotypic testing methods may not be able to detect the resistance in a mixed culture. The mixed culture may contain a resistant organism and a susceptible organism. The phenotypic result may be susceptible.

Biological Limitations

The resistance gene may be present but not expressed. The gene may be silent. The gene may be expressed at a low level. The gene may be expressed only under certain conditions.

The resistance gene may be present but not functional. The gene may be truncated. The gene may have a mutation. The gene may be a pseudogene.

The resistance gene may be present but the protein may not be functional. The protein may be misfolded. The protein may not be localized to the correct location. The protein may not be active.

Case Examples of Discordance

Case 1: Silent Beta-Lactamase Gene

An environmental isolate of a Gram-negative bacterium was sequenced and found to contain a beta-lactamase gene. The isolate was tested for susceptibility to ampicillin and was found to be susceptible. The discordance was investigated.

The gene sequence was examined and was found to be intact. The promoter region was examined and was found to be intact. The gene expression was measured and was found to be low. The gene was not expressed at a level that was sufficient to confer resistance.

The conclusion was that the gene was present but was not expressed. The gene was a silent gene. The isolate was susceptible to ampicillin because the gene was not expressed.

Case 2: A Novel Efflux Pump

An environmental isolate was tested for susceptibility to tetracycline and was found to be resistant. The isolate was sequenced and was found to not contain a known tetracycline resistance gene. The discordance was investigated.

The isolate was screened for alternative mechanisms. The isolate was found to have an efflux pump that was not annotated as a resistance gene. The efflux pump was able to pump tetracycline out of the cell.

The conclusion was that the isolate was resistant to tetracycline through an efflux pump. The efflux pump was not annotated as a resistance gene. The discordance was resolved.

Case 3: A Database Error

An environmental isolate was sequenced and was found to contain a resistance gene. The isolate was tested for susceptibility to the antimicrobial agent and was found to be susceptible. The discordance was investigated.

The gene sequence was examined. The gene was found to be a variant of a known resistance gene. The variant was not in the database. The database had a different variant.

The conclusion was that the gene was a variant of a known resistance gene. The variant was not in the database. The database was incomplete.

The Role of Discordance in Surveillance and Stewardship

Surveillance Implications

Discordance has important implications for surveillance. Surveillance programs that rely on genotypic data may overestimate the prevalence of resistance. The presence of a resistance gene does not mean that the organism is resistant. The gene may be silent or non-functional.

Surveillance programs that rely on phenotypic data may underestimate the prevalence of resistance. The phenotypic test may not be able to detect the resistance mechanism. The phenotypic test may not be appropriate for the environmental isolate.

The surveillance programs should use both phenotypic and genotypic data. The data should be interpreted together. The discordance should be investigated.

Stewardship Implications

Discordance has important implications for stewardship. The stewardship programs are designed to reduce the use of antimicrobial agents. The stewardship programs rely on accurate data to make decisions.

The discordance may lead to the inappropriate use of antimicrobial agents. The isolate may be resistant to an antimicrobial agent, but the resistance may not be detected. The isolate may be susceptible to an antimicrobial agent, but the resistance may be detected.

The stewardship programs should use the data to make decisions. The data should be interpreted in the context of the discordance.

A Practical Decision Framework for Discordance Resolution

Investigating phenotypic genotypic discordance in environmental isolates can consume substantial laboratory time and resources. A structured decision framework helps researchers determine when to pursue deeper investigation, when to accept a result, and when to escalate the issue. The framework below organizes the investigation into three tiers based on the risk and consequence of the discordant result.

Tier 1: Screening Discordance

The first tier applies when discordance is identified during routine screening and the isolate is not associated with a high-consequence application. Screening discordance includes cases where the isolate is from a low-risk environmental source, the antimicrobial agent is not clinically critical, or the isolate will not be used for further studies.

For Tier 1 discordance, perform the following minimum checks:

• Confirm the isolate is pure by streaking on non-selective medium and examining colony morphology
• Repeat the phenotypic susceptibility test once using the same method
• Verify the resistance gene detection using the same database with default parameters
• Document the discordance in the laboratory records

If the repeat phenotypic test confirms the original result and the gene detection is reproducible, the discordance can be recorded as unresolved without further investigation. The World Health Organization notes that antimicrobial resistance surveillance requires accurate data, but not every discordant environmental isolate warrants full molecular characterization. The laboratory should document the discordance and the rationale for not pursuing further investigation.

Tier 2: Investigative Discordance

The second tier applies when the isolate has potential public health relevance, the antimicrobial agent is clinically important, or the isolate will be used in downstream applications such as resistance gene transfer studies or comparative genomics. Investigative discordance requires the full systematic workflow described in the previous sections.

The Tier 2 workflow includes:

• Confirm species identification using an independent method such as 16S rRNA gene sequencing or MALDI-TOF mass spectrometry
• Repeat the phenotypic test using a second independent method such as disk diffusion or agar dilution
• Examine the resistance gene sequence for truncations, frameshift mutations, and promoter disruptions
• Assess gene expression using RT-PCR or RNA sequencing
• Repeat the database search with updated database versions and multiple databases
• Screen for alternative resistance mechanisms including target mutations and efflux pumps

The American Type Culture Collection provides authenticated reference strains that should be used as controls throughout the Tier 2 investigation. These strains ensure that the testing system is functioning correctly and provide a baseline for comparing results.

Tier 3: Escalation Discordance

The third tier involves discordance that cannot be resolved with the available laboratory resources or expertise. Escalation is appropriate when the discordance involves a novel resistance mechanism, a clinically critical antimicrobial agent, or a potential public health threat.

Escalation criteria include:

• The isolate shows phenotypic resistance to a last-resort antimicrobial agent with no identifiable genetic mechanism
• The isolate carries a resistance gene with no detectable expression despite intact sequence and promoter
• The discordance persists after completing all Tier 2 investigation steps
• The isolate is suspected to carry a novel resistance gene that is not represented in any current database

When escalating, the laboratory should prepare a complete record of the investigation including all phenotypic results, sequence data, expression data, and database search results. The record should be sent to a reference laboratory with the isolate preserved in a viable state. The Biosafety in Microbiological and Biomedical Laboratories guidance should be followed when shipping the isolate to ensure proper containment and decontamination procedures.

Decision Points and Documentation

The decision framework uses three explicit decision points. The first decision point occurs after the initial discordance is identified. The researcher must decide whether the discordance is Tier 1 or Tier 2 based on the isolate source and the antimicrobial agent. The second decision point occurs after the Tier 2 investigation is complete. The researcher must decide whether the discordance is resolved or requires escalation. The third decision point occurs when the discordance remains unresolved. The researcher must decide whether to report the discordance as unresolved or to exclude the isolate from the study.

Each decision point should be documented in the laboratory records with the rationale for the decision. The documentation should include the date, the researcher name, the isolate identifier, and the specific evidence that supported the decision. This documentation provides a clear audit trail and supports the reproducibility of the investigation.

Applying the Framework to a Discordance Case

Consider an environmental isolate from a water sample that shows phenotypic resistance to ciprofloxacin but has no detectable quinolone resistance gene in its genome. The isolate is from a routine environmental survey and ciprofloxacin is not the primary focus of the study. This case falls into Tier 1. The laboratory confirms the isolate is pure, repeats the susceptibility test, and repeats the gene detection. If the results are consistent, the discordance is recorded as unresolved and the isolate is not investigated further.

If the same isolate is from a clinical environment or the study is focused on fluoroquinolone resistance, the case falls into Tier 2. The laboratory confirms the species, repeats the susceptibility test using disk diffusion, examines the genome for target mutations in the quinolone resistance determining region, and screens for efflux pumps. If the investigation identifies a target mutation, the discordance is resolved. If no mechanism is found, the case may be escalated to a reference laboratory.

Common Failure Patterns in the Decision Framework

The most common failure in applying the decision framework is skipping Tier 1 checks and moving directly to Tier 2 investigation. This wastes resources on isolates that do not require full investigation. The second most common failure is failing to document the decision points. Without documentation, the investigation cannot be reproduced or reviewed. The third common failure is escalating cases that should be resolved at Tier 2. Escalation should be reserved for cases that genuinely require additional resources.

Quality Assurance for the Decision Framework

The decision framework should be reviewed regularly by the laboratory director or the quality assurance officer. The review should assess whether the decision points are being applied consistently and whether the documentation is complete. The American Society for Microbiology provides professional education and training resources that can support the laboratory workforce in applying the framework consistently. The laboratory should also participate in proficiency testing programs to ensure that the phenotypic and genotypic methods are performing correctly.

The decision framework is not a substitute for the systematic investigation workflow. It is a tool for allocating resources efficiently and ensuring that discordance cases are investigated at the appropriate level of detail. The framework should be adapted to the specific needs of the laboratory and the research program.

Frequently Asked Questions

What is the most common cause of phenotypic genotypic discordance in environmental bacteria?

The most common cause is the presence of a resistance gene that is not expressed. The gene may be silent, or the gene may be expressed at a low level. The gene may be present in the genome but not be transcribed or translated.

How should I confirm that a discordant result is not a technical error?

Confirm the purity of the isolate, repeat the phenotypic test using the same and a different method, and include quality control strains in each test run. If the repeat results are consistent, the discordance is likely to be real.

What should I do if the resistance gene is present but the isolate is phenotypically susceptible?

Examine the gene sequence for mutations that would disrupt the function. Check the promoter region for mutations that would disrupt transcription. Measure the gene expression to determine if the gene is transcribed.

What should I do if the isolate is phenotypically resistant but no resistance gene is detected?

Screen for alternative resistance mechanisms, including target mutations, efflux pumps, and changes in membrane permeability. The resistance may be due to a mechanism that is not annotated as a resistance gene.

How do I choose the right database for resistance gene detection?

Use multiple databases and compare the results. The databases have different content and different search parameters. The database should be current and should be updated regularly.

Can I use clinical breakpoints to interpret the susceptibility of environmental isolates?

The clinical breakpoints are designed for clinical isolates and may not be appropriate for environmental isolates. The breakpoints may not be appropriate for the environmental isolate. The breakpoints should be used with caution.

What is the role of quality control strains in discordance investigation?

The quality control strains are used to ensure that the test is working correctly. The quality control strains have known MIC patterns. The quality control results should be within the expected range.

When should I escalate a discordance investigation to a reference laboratory?

The discordance investigation should be escalated to a reference laboratory when the investigation cannot be completed in the local laboratory. The reference laboratory may have additional resources for the investigation.

Using the Evidence

Related Bacteriology Guides

• Chicken Bacteria in Bangladesh: Epidemiology, Antimicrobial Resistance, and Food Safety Implications
• Biological Foundation Models for Antimicrobial Peptide Discovery in Veterinary Pathogens
• Aeromonas hydrophila in Aquaculture: Virulence Factors and Antimicrobial Resistance
• Swine Bacterial Diseases: Colibacillosis, UTI, and Antimicrobial Resistance
• Avian Colibacillosis: Pathogenesis, Diagnosis, and Antimicrobial Resistance Patterns in Poultry

References and Further Reading

• Biosafety in Microbiological and Biomedical Laboratories. CDC and NIH.
• Microbiology Resources. American Society for Microbiology.
• Antimicrobial Resistance. World Health Organization.
• Bacteriological Analytical Manual. U.S. Food and Drug Administration.
• Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute.
• Culture Collections. American Type Culture Collection.
• NCBI Pathogen Detection. National Center for Biotechnology Information.
• Phenotype-Genotype Discordance in Antimicrobial Resistance of &lt,i&gt,Acinetobacter baumannii&lt,/i&gt,: Implications for Diagnostics and Surveillance.. 2026.
• Antimicrobial Resistance and Biofilm in Bacteria from Rehabilitated Sapajus libidinosus.. 2026.
• Antimicrobial Resistance Profiles of Gram-Negative Bacteria Isolated from Saker Falcons (&lt,i&gt,Falco cherrug&lt,/i&gt,) in Western Romania.. 2026.
• Pathoadaptive evolution and clonal dissemination of community- associated methicillin-resistant Staphylococcus aureus in Egypt.. 2026.

This article is educational and does not replace validated laboratory procedures, clinical diagnosis, institutional biosafety review, or public-health guidance.